DEF: MariMed Inc. Seeks Stockholder Approval for Reverse Stock Split

MariMed Inc. has issued a proxy statement to its stockholders seeking approval for a reverse stock split, ranging from 1-for-50 to 1-for-100, to potentially list on NYSE American or Nasdaq.

Summary

• MariMed Inc. is holding a special meeting of stockholders on October 28, 2026, to vote on two proposals.
• The primary proposal is to approve an amendment to the Certificate of Incorporation to effect a reverse stock split of common stock, with a ratio between 1-for-50 and 1-for-100.
• The exact ratio and timing of the reverse stock split will be determined by the Board of Directors.
• The Board can also choose to abandon the reverse stock split even if approved by stockholders.
• The second proposal is to approve the adjournment of the meeting if necessary to solicit more votes for the reverse stock split proposal.
• The record date for determining stockholders entitled to vote is September 4, 2026.
• The company's common stock was trading between $0.0652 and $0.0935 during the 30-day period ending September 18, 2026.
• Fractional shares resulting from the split will be paid in cash.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral to slightly negative filing, primarily due to the necessity of a reverse stock split, which often signals underlying stock price weakness, though it aims to improve listing prospects.

Positives

• The reverse stock split aims to increase the market price of common shares, potentially facilitating a listing on the NYSE American or Nasdaq.
• A higher stock price may attract a broader range of institutional investors and increase analyst and broker interest.
• The Board of Directors has the discretion to set the exact ratio and timing, or to abandon the split if deemed not in the best interest of stockholders.
• The company is seeking to improve its stock's marketability and investor appeal.

Negatives

• The necessity of a reverse stock split often indicates a history of declining stock prices and may not guarantee a future price increase.
• There is no assurance that the reverse stock split will result in a proportionate increase in the stock price or that the company will meet listing requirements.
• The company's U.S. cannabis operations present a significant hurdle for listing on national exchanges due to federal law.
• The reverse stock split may decrease the liquidity of the common shares and increase transaction costs for stockholders holding odd lots.

Risks

• The market price of common shares may not increase sufficiently to meet the Minimum Bid Price Requirement for NYSE American or Nasdaq listing.
• The company may be unable to list on national exchanges due to its U.S. cannabis operations and current federal law, even if the stock price increases.
• The stock price could fall after the reverse stock split, potentially leading to delisting from any exchange.
• The reverse stock split may decrease liquidity and increase transaction costs for stockholders.
• The reverse stock split may not achieve its intended benefits, and the share price will continue to be influenced by operational performance and market conditions.
• The reverse stock split could create odd-lot holdings, reducing liquidity and increasing transaction costs for some stockholders.
• The increase in authorized but unissued shares could be used by the Board to thwart a takeover attempt.

Future Outlook

The company's primary forward-looking statement relates to the potential listing on NYSE American or Nasdaq following a successful reverse stock split, which is contingent on meeting listing requirements and potential changes in U.S. federal cannabis laws.

Management Comments

• The Board believes that effecting the Reverse Stock Split may be desirable to increase the market price per share of our Common Shares and thereby assist the Company in satisfying the applicable Minimum Bid Price Requirement for an initial listing on NYSE American or Nasdaq.
• We believe the Reverse Stock Split may increase the price of our Common Shares and thus may provide a broader range of institutional investors with the ability to invest in our Common Shares.
• We believe the Reverse Stock Split would help increase analyst and broker-dealer interest in our Common Shares as many brokerage and investment advisory firms policies can discourage analysts, advisors, and broker-dealers from following or recommending companies with low stock prices.
• The Board recommends that stockholders vote FOR the Amendment Proposal and FOR the Adjournment Proposal.

Industry Context

StockSavvy.ai notes that reverse stock splits are a common strategy for companies seeking to uplist to major exchanges like NYSE American or Nasdaq, which have minimum bid price requirements. However, the cannabis industry faces unique regulatory challenges in the U.S., which can impede listing on national exchanges regardless of stock price.

Stakeholder Impact

• Shareholders will have fewer shares, but the total value of their holdings is intended to increase proportionally, though this is not guaranteed.
• Shareholders holding fractional shares will receive cash in lieu, potentially realizing a capital gain or loss.
• The reverse stock split may increase the number of shareholders who own odd lots, potentially increasing their transaction costs.
• Institutional investors may find the stock more accessible if the price increases, potentially broadening the investor base.

Next Steps

• Stockholders to vote on the Amendment Proposal and Adjournment Proposal at the Special Meeting on October 28, 2026.
• If approved, the Board will determine whether and when to effect the reverse stock split and the exact ratio.
• If the reverse stock split is implemented, the Certificate of Incorporation will be amended and filed with the Secretary of State of Delaware.
• The company will file a Form 8-K with preliminary and final voting results after the Special Meeting.

Key Dates

Recommendation

The filing is a procedural step to address stock price and listing requirements, not a report on financial performance. While the reverse stock split aims to improve marketability, significant risks remain, particularly related to U.S. federal cannabis laws and the uncertainty of stock price appreciation. Therefore, a 'hold' recommendation is prudent pending further developments and clarity on listing prospects.

Keywords

Reverse Stock Split, MariMed Inc., Stockholder Meeting, Certificate of Incorporation Amendment, NYSE American Listing, Nasdaq Listing, CSE Policy, Proxy Statement